Rajesh Shinde
Vertrieb & Marketing bei ZOTA HEALTH CARE LIMITED
Profil
Rajesh Shinde is currently working as the Manager-National Sales at Zota Health Care Ltd.
since 2016.
Prior to this, he worked as the Manager-National Sales at Astra IDL Ltd.
and as the Manager-Area Business at Emcure Pharmaceuticals Ltd.
Aktive Positionen von Rajesh Shinde
| Unternehmen | Position | Beginn |
|---|---|---|
| ZOTA HEALTH CARE LIMITED | Vertrieb & Marketing | 12.01.2016 |
Ehemalige bekannte Positionen von Rajesh Shinde
| Unternehmen | Position | Ende |
|---|---|---|
Emcure Pharmaceuticals Ltd.
 Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Corporate Officer/Principal | - |
| Astra IDL Ltd. | Vertrieb & Marketing | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ZOTA HEALTH CARE LIMITED | Health Technology |
| Private Unternehmen | 2 |
|---|---|
| Astra IDL Ltd. | Health Technology |
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Health Technology |